Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SNGX
SNGX logo

SNGX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Soligenix Inc (SNGX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.340
1 Day change
-19.72%
52 Week Range
6.230
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Soligenix Inc (SNGX) is not a strong buy at this moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of significant news or catalysts, and no clear trading signals suggest that holding off on investment is prudent until stronger growth indicators or opportunities arise.

Technical Analysis

The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is in the neutral zone, and moving averages are converging, showing no clear trend. The stock is currently trading pre-market at $1.35, slightly above the pivot level of $1.257 but below the first resistance level of $1.383.

Positive Catalysts

  • NULL identified. No recent news or significant insider/hedge fund activity.

Neutral/Negative Catalysts

  • Financial performance is weak, with declining net income (-3.05% YoY) and EPS (-75.63% YoY). No recent news or catalysts to drive growth.

Financial Performance

In Q4 2025, revenue remained at $0 with no growth. Net income dropped to -$2,896,189 (-3.05% YoY), and EPS fell significantly by -75.63% YoY to -$0.29. Gross margin remained at 0%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available.

Wall Street analysts forecast SNGX stock price to rise
1 Analyst Rating
Wall Street analysts forecast SNGX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.421
sliders
Low
10
Averages
10
High
10
Current: 0.421
sliders
Low
10
Averages
10
High
10
Alliance Global Partners
James Molloy
Buy
downgrade
$10 -> $6
AI Analysis
2025-07-16
Reason
Alliance Global Partners
James Molloy
Price Target
$10 -> $6
AI Analysis
2025-07-16
downgrade
Buy
Reason
Alliance Global Partners analyst James Molloy lowered the firm's price target on Soligenix to $6 from $10 and keeps a Buy rating on the shares after the company reported recent corporate updates and clinical progress of HyBryte. The firm says its price target represents a sum-of-the-parts.

People Also Watch